The session, held at the Barcelona Medical Association on 5 October, presented start-ups specializing in biotechnology, medical devices and healthcare services
The spin-off of the Josep Carreras Leukemia Research Institute, founded in 2015, develops a new class of drugs for the treatment of acute myeloid leukemia
These include usMIMA, one of the companies to come out of the Design Health Barcelona master, which has been selected to pitch its project to investors
